{"release":"wpf-claim-checks","version":"1.6.0","checkedOn":"2026-11-14","verificationLabel":"AI-assisted source verification","humanReview":"none recorded","claim":{"id":"ss-31-slows-aging","claimWording":"SS-31 (elamipretide) reverses or slows aging in people.","wordingKind":"representative","quoted":null,"title":"SS-31 and aging","peptides":["elamipretide"],"aliases":["SS-31","Bendavia","MTP-131","Forzinity"],"topics":["effectiveness"],"verdict":"overstated","plainAnswer":"A single dose improved a short-lived muscle-energy measurement in older adults, but it did not improve fatigue resistance and the effect was gone a week later. That is not evidence that it slows aging.","scope":{"population":"39 healthy adults aged 60 to 85 selected for poorly functioning muscle mitochondria","design":"Randomized, double-blind, placebo-controlled, single-dose trial (phase 2) measuring muscle mitochondrial energetics by spectroscopy","boundary":"Short-term muscle mitochondrial capacity in older adults. Not lifespan, healthspan, disease or any aging endpoint, and not the approved Barth syndrome use."},"strongest":[{"label":"In vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial (PLoS One, 2021; PMID 34264994)","url":"https://pubmed.ncbi.nlm.nih.gov/34264994/","kind":"Peer-reviewed paper","population":"39 healthy older adults, 60 to 85 years, 46% female, enrolled for poorly functioning mitochondria","design":"Randomized, double-blind, placebo-controlled, single 2-hour infusion","locator":"Abstract, Results: change in maximal ATP production (ATPmax) P = 0.055 and percent change P = 0.045 immediately after infusion; no difference on day 7; no significant change in resting coupling; no significant effect on fatigue resistance."},{"label":"MTP-131 (Bendavia) on skeletal muscle function in the elderly (NCT02245620)","url":"https://clinicaltrials.gov/study/NCT02245620?tab=results","kind":"Registry record","population":"41 participants aged 60 to 85 (actual)","design":"Registered phase 2 trial, results posted 2020-06-23","locator":"Results tab, primary outcome measure: change from baseline in ATPmax, mean 0.17 (SD 0.196) for MTP-131 and 0.12 (SD 0.244) for placebo, at 2 hours after the start of infusion and day 7; no between-group analysis is posted."},{"label":"Study of Healthy Aging and Physical Function With Elamipretide (NCT07275424)","url":"https://clinicaltrials.gov/study/NCT07275424","kind":"Registry record","population":"30 participants planned, age 65 and over","design":"Registered phase 2 trial, recruiting since 2025-11-26","locator":"Record header: status Recruiting; no results posted."}],"uncertain":["The headline effect was borderline (P = 0.055 and 0.045 on two versions of the measure) in a small trial, and no primary-endpoint threshold is stated in the abstract WPF read.","The registry's posted group values (41 participants) and the paper's analysis set (39) differ in size and are not the same analysis; WPF did not reconcile them.","Mouse and cell studies of SS-31 in aging exist in the literature (80 PubMed records matched aging terms) but were not summarized here."],"wouldChange":["A longer randomized trial in older adults with a clinical or functional aging outcome (for example mobility, strength or frailty) showing a benefit that lasts after dosing.","Posted results from NCT07275424 or similar trials."],"gaps":["No human trial of elamipretide with an aging, healthspan or lifespan outcome was found. The animal aging literature was counted but not read."],"searchScope":{"searchedOn":"2026-11-14","sources":["PubMed","ClinicalTrials.gov API v2"],"queries":["PubMed: (elamipretide OR SS-31 OR MTP-131 OR Bendavia) in title/abstract -> 473 records","PubMed: the same terms AND (aging OR ageing OR older adults OR aged OR sarcopenia) -> 80 records","PubMed: (elamipretide OR SS-31) AND (aging OR older) AND (randomized OR clinical trial) -> 4 records, one a human randomized trial in older adults (PMID 34264994)","ClinicalTrials.gov: query.intr=elamipretide -> 25 registrations, two in older or healthy-aging populations (NCT02245620, NCT07275424)"],"found":"One completed randomized single-dose trial in older adults with a mitochondrial measure, and one registered healthy-aging trial that is still recruiting.","notSearched":["Full text of the 80 aging-related PubMed records","Embase","Unregistered studies"]},"regulatory":null,"checkedOn":"2026-11-14","links":{"profiles":["/directory/elamipretide"],"films":[],"flagship":[],"journeys":["/research/journey/elamipretide"],"teaching":[],"changes":["/research/changes#trial_result_posted"]},"extends1_0_0":false},"sha256":"48659670c6d352b5285205cf90eff97493ec4a383d348ea8304e33981cc25595"}